Cardiovascular Drug Development Using Radiopharmaceuticals

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|9|935-942

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.9, 2009-03, pp. : 935-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Drug Development Using Glucose Metabolism Radiopharmaceuticals

By  

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 983-987

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals, Drug Development and Pharmaceutical Regulations in Europe

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 7-11

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective

By  

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 957-965

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience

By  

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 950-956

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals for Drug Development: United States Regulatory Perspective

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite